A simple heuristic for allocating opioid settlement funding to reduce overdose mortality in the United States

References

• Mattson CL. Trends and geographic patterns in drug and synthetic opioid overdose deaths – United States, 2013–2019. MMWR Morb Mortal Wkly Rep. 2021;70:202–207. doi: 10.15585/mmwr.mm7006a4.
   PubMed Web of Science ®Google Scholar
• Imtiaz S, Nafeh F, Russell C, Ali F, Elton-Marshall T, Rehm J. The impact of the novel coronavirus disease (COVID-19) pandemic on drug overdose-related deaths in the United States and Canada: a systematic review of observational studies and analysis of public health surveillance data. Subst Abuse Treat Prev Policy. 2021;16:87. doi: 10.1186/s13011-021-00423-5.
   PubMed Web of Science ®Google Scholar
• Friedman J, Akre S. COVID-19 and the drug overdose crisis: uncovering the deadliest months in the United States, January‒July 2020. Am J Public Health. 2021;111:1284–291. doi: 10.2105/AJPH.2021.306256.
   PubMed Web of Science ®Google Scholar
• Cartus AR, Li Y, Macmadu A, Goedel WC, Allen B, Cerdá M, Marshall BDL. Forecasted and observed drug overdose deaths in the US during the COVID-19 pandemic in 2020. JAMA Netw Open. 2022;5:e223418. doi: 10.1001/jamanetworkopen.2022.3418.
   PubMed Web of Science ®Google Scholar
• Drug Overdose Death Rates. National Institute on Drug Abuse. [accessed 2023 Nov 15]. https://nida.nih.gov/research-topics/trends-statistics/overdose-death-rates.
   Google Scholar
• Park JN, Rouhani S, Beletsky L, Vincent L, Saloner B, Sherman SG. Situating the continuum of overdose risk in the social determinants of health: a new conceptual framework. Milbank Q. 2020;98:700–746. doi: 10.1111/1468-0009.12470.
   PubMed Web of Science ®Google Scholar
• Macmadu A, Batthala S, Correia Gabel AM, Rosenberg M, Ganguly R, Yedinak JL, Hallowell BD, Scagos RP, Samuels EA, Cerdá M, et al. Comparison of characteristics of deaths from drug overdose before vs during the COVID-19 pandemic in Rhode Island. JAMA Netw Open. 2021;4:e2125538. doi: 10.1001/jamanetworkopen.2021.25538.
   PubMed Web of Science ®Google Scholar
• Kariisa M, Davis NL, Kumar S, Seth P, Mattson CL, Chowdhury F, Jones CM. Vital signs: drug overdose deaths, by selected sociodemographic and social determinants of health characteristics — 25 States and the District of Columbia, 2019–2020. MMWR Morb Mortal Wkly Rep. 2022;71:940–947. doi: 10.15585/mmwr.mm7129e2.
   PubMed Web of Science ®Google Scholar
• Schneider KE, Allen ST, Rouhani S, Morris M, Haney K, Saloner B, Sherman SG. Increased solitary drug use during COVID-19: an unintended consequence of social distancing. Int J Drug Policy. 2023;111:103923. doi: 10.1016/j.drugpo.2022.103923.
   PubMed Web of Science ®Google Scholar
• National Opioids Settlement. [accessed 2023 Aug 15]. https://nationalopioidsettlement.com/.
   Google Scholar
• Principles for the Use of Funds from the Opioid Litigation. Johns Hopkins Bloomberg School of Public Health. [accessed 2023 Nov 15]. https://opioidprinciples.jhsph.edu/.
   Google Scholar
• From the War on Drugs to Harm Reduction. Imagining a just response to the overdose Crisis. Harvard University FXB Center for Health & Human Rights; 2020 Dec 16 [accessed 2023 Nov 15]. https://fxb.harvard.edu/warondrugstoharmreduction/.
   Google Scholar
• Evidence Based Strategies for Abatement of Harms from the Opioid Epidemic. Legal action center. 2020 Oct [accessed 2023 Nov 15]. https://www.lac.org/resource/evidence-based-strategies-for-abatement-of-harms-from-the-o.
   Google Scholar
• Sharfstein JM, Olsen Y. How not to spend an opioid settlement. JAMA. 2020;323:1031–1032. doi: 10.1001/jama.2020.1371.
   PubMed Web of Science ®Google Scholar
• Pack P, Healton RG, Galea C. Maximizing public benefit from opioid settlement resources. Milbank Q. 2020;98:26–30. doi: 10.1111/1468-0009.12450.
   PubMed Web of Science ®Google Scholar
• Hawkins D. Louisiana will get $325M from a major opioid settlement. Advocates want to know how it will be spent. WWNO; 2023 July 18 [accessed 2023 Nov 15]. https://www.wwno.org/public-health/2023-07-18/louisiana-will-get-325m-from-a-major-opioid-settlement-advocates-want-to-know-how-it-will-be-spent.
   Google Scholar
• Shuler J. Ohio republicans’ rotten scheme to spend opioid settlement money in secret. New repub. 2023 July 10 [accessed 2023 Nov 15]. https://newrepublic.com/article/174116/ohio-republicans-rotten-scheme-spend-opioid-settlement-money-secret.
   Google Scholar
• Pattani A. Law enforcement eyes opioid settlement cash for squad cars and body scanners. NPR; 2023 Oct 20 [accessed 2023 Nov 15]. https://www.npr.org/sections/health-shots/2023/10/20/1206326239/law-enforcement-eyes-opioid-settlement-cash-for-squad-cars-and-body-scanners.
   Google Scholar
• Stringfellow EJ, Lim TY, Humphreys K, DiGennaro C, Stafford C, Beaulieu E, Homer J, Wakeland W, Bearnot B, McHugh RK, et al. Reducing opioid use disorder and overdose deaths in the United States: a dynamic modeling analysis. Sci Adv. 2022;8:eabm8147. doi: 10.1126/sciadv.abm8147.
   PubMed Web of Science ®Google Scholar
• Nataraj N, Rikard SM, Zhang K, Jiang X, Guy GP, Rice K, Mattson CL, Gladden RM, Mustaquim DM, Illg ZN, et al. Public health interventions and overdose-related outcomes among persons with opioid use disorder. JAMA Netw Open. 2024;7:e244617. doi: 10.1001/jamanetworkopen.2024.4617.
   PubMed Web of Science ®Google Scholar
• U.S. of America Demographics. Data Commons. [accessed 2023 Nov 15]. https://datacommons.org/place/country/USA?category=Demographics.
   Google Scholar
• Bradley H, Hall EW, Asher A, Furukawa NW, Jones CM, Shealey J, Buchacz K, Handanagic S, Crepaz N, Rosenberg ES, et al. Estimated number of people who inject drugs in the United States. Clin Infect Dis. 2023;76:96–102. doi: 10.1093/cid/ciac543.
   PubMed Web of Science ®Google Scholar
• Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP, et al. Estimated prevalence of opioid use disorder in Massachusetts, 2011–2015: a capture–recapture analysis. Am J Public Health. 2018;108:1675–1681. doi: 10.2105/AJPH.2018.304673.
   PubMed Web of Science ®Google Scholar
• Wang J, Doogan N, Thompson K, Bernson D, Feaster D, Villani J, Chandler R, White LF, Kline D, Barocas JA, et al. Massachusetts prevalence of opioid use disorder estimation revisited: comparing a bayesian approach to standard capture–recapture methods. Epidemiology. 2023;34:841–849. doi: 10.1097/EDE.0000000000001653.
   PubMed Web of Science ®Google Scholar
• Shealey J, Hall EW, Pigott TD, Bradley H. Systematic review and meta-analysis to estimate the burden of fatal and non-fatal overdose among people who inject drugs. medRxiv. 2022 Feb 21: 2022–02.
   Google Scholar
• Casillas SM, Pickens CM, Tanz LJ, Vivolo-Kantor AM. Estimating the ratio of fatal to non-fatal overdoses involving all drugs, all opioids, synthetic opioids, heroin or stimulants, USA, 2010–2020. Inj Prev. 2024;30:114–24. doi: 10.1136/ip-2023-045091.
   PubMed Web of Science ®Google Scholar
• 2020 NSDUH Detailed Tables. Substance abuse and mental health services administration. [accessed 2023 Nov 15]. https://www.samhsa.gov/data/report/2020-nsduh-detailed-tables.
   Google Scholar
• Hochstatter KR, Akhtar WZ, Dietz S, Pe-Romashko K, Gustafson DH, Shah DV, Krechel S, Liebert C, Miller R, El-Bassel N, et al. Potential influences of the COVID-19 pandemic on drug use and HIV care among people living with HIV and substance use disorders: experience from a pilot mHealth intervention. AIDS Behav. 2021;25:354–359. doi: 10.1007/s10461-020-02976-1.
   PubMed Web of Science ®Google Scholar
• Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;173:61–62. doi: 10.7326/M20-1212.
   PubMed Web of Science ®Google Scholar
• Mercer F, Miler JA, Pauly B, Carver H, Hnízdilová K, Foster R, Parkes T. Peer support and overdose prevention responses: a systematic ‘state-of-the-art’ review. Int J Environ Res Public Health. 2021;18:12073. doi: 10.3390/ijerph182212073.
   PubMed Web of Science ®Google Scholar
• Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357:j1550. doi: 10.1136/bmj.j1550.
   PubMed Web of Science ®Google Scholar
• Santo T, Clark B, Hickman M, Grebely J, Campbell G, Sordo L, Chen A, Tran LT, Bharat C, Padmanathan P, et al. Association of opioid agonist treatment with all-cause mortality and specific causes of death among people with opioid dependence. JAMA Psychiarty. 2021;78:979–993. doi: 10.1001/jamapsychiatry.2021.0976.
   PubMed Web of Science ®Google Scholar
• Goedel WC, Green TC, Viner-Brown S, Rich JD, Marshall BDL. Increased overdose mortality during the first week of the month: revisiting the “check effect” through a spatial lens. Drug Alcohol Depend. 2019;197:49–55. doi: 10.1016/j.drugalcdep.2018.12.024.
   PubMed Web of Science ®Google Scholar
• Bradford AC, Bradford WD. The effect of evictions on accidental drug and alcohol mortality. Health Serv Res. 2020;55:9–17. doi: 10.1111/1475-6773.13256.
   PubMed Web of Science ®Google Scholar
• Wu P, Evangelist M. Unemployment insurance and opioid overdose mortality in the United States. Demography. 2022;59:485–509. doi: 10.1215/00703370-9772414.
   PubMed Web of Science ®Google Scholar
• Peiper NC, Duhart Clarke S, Vincent LB, Ciccarone D, Kral AH, Zibbell JE. Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States. Int J Drug Policy. 2019;63:122–128. doi: 10.1016/j.drugpo.2018.08.007.
   PubMed Web of Science ®Google Scholar
• Maghsoudi N, Tanguay J, Scarfone K, Rammohan I, Ziegler C, Werb D, Scheim AI. Drug checking services for people who use drugs: a systematic review. Addiction. 2022;117:532–544. doi: 10.1111/add.15734.
   PubMed Web of Science ®Google Scholar
• Shell Tilhou A, Zaborek J, Baltes A, Salisbury-Afshar E, Malicki J, Brown R. Differences in drug use behaviors that impact overdose risk among individuals who do and do not use fentanyl test strips for drug checking. Harm Reduct J. 2023;20. doi: 10.1186/s12954-023-00767-0.
   Web of Science ®Google Scholar
• Reed MK, Roth AM, Tabb LP, Groves AK, Lankenau SE. “I probably got a minute”: perceptions of fentanyl test strip use among people who use stimulants. Int J Drug Policy. 2021;92:103147. doi: 10.1016/j.drugpo.2021.103147.
   PubMed Web of Science ®Google Scholar
• Krieger MS, Yedinak JL, Buxton JA, Lysyshyn M, Bernstein E, Rich JD, Green TC, Hadland SE, Marshall BDL. High willingness to use rapid fentanyl test strips among young adults who use drugs. Harm Reduct J. 2018;15:7. doi: 10.1186/s12954-018-0213-2.
   PubMed Web of Science ®Google Scholar
• Frkovich J, Hedrick H, Anakaraonye AR, Bornkessel A, Lefebvre RC. Opioid-related public health communication campaigns: an environmental scan. Am J Health Promot. 2022;36:913–919. doi: 10.1177/08901171221082471.
   PubMed Web of Science ®Google Scholar
• Bratberg JP, Simmons A, Arya V, Bhatia A, Vakharia SP. Support, don’t punish: drug decriminalization is harm reduction. J Am Pharm Assoc. 2023;63:224–229. doi: 10.1016/j.japh.2022.12.017.
   Google Scholar
• Pamplin JR, Rouhani S, Davis CS, King C, Townsend TN. Persistent criminalization and structural racism in US drug policy: the case of overdose good Samaritan laws. Am J Public Health. 2023;113:S43–S48. doi: 10.2105/AJPH.2022.307037.
   PubMed Web of Science ®Google Scholar
• Strang J, Powis B, Best D, Vingoe L, Griffiths P, Taylor C, Welch S, Gossop M. Preventing opiate overdose fatalities with take-home naloxone: pre-launch study of possible impact and acceptability. Addict Abingdon Engl. 1999;94:199–204. doi: 10.1046/j.1360-0443.1999.9421993.x.
   PubMed Web of Science ®Google Scholar
• Fairbairn N, Coffin PO, Walley AY. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: challenges and innovations responding to a dynamic epidemic. Int J Drug Policy. 2017;46:172–179. doi: 10.1016/j.drugpo.2017.06.005.
   PubMed Web of Science ®Google Scholar
• Irvine MA, Oller D, Boggis J, Bishop B, Coombs D, Wheeler E, Doe-Simkins M, Walley AY, Marshall BDL, Bratberg J, et al. Estimating naloxone need in the USA across fentanyl, heroin, and prescription opioid epidemics: a modelling study. Lancet Public Health. 2022;7:e210–e218. doi: 10.1016/S2468-2667(21)00304-2.
   PubMed Web of Science ®Google Scholar
• Wojcicki JM. Dying alone: the sad irrelevance of naloxone in the context of solitary opiate use. Addiction. 2019;114:574–575. doi: 10.1111/add.14508.
   PubMed Web of Science ®Google Scholar
• Hughes CE, Stevens A. What can we learn from the Portuguese decriminalization of illicit drugs? Br J Criminol. 2010;50:999–1022. doi: 10.1093/bjc/azq038.
   Web of Science ®Google Scholar
• Ray B, Korzeniewski SJ, Mohler G, Carroll JJ, Del Pozo B, Victor G, Huynh P, Hedden BJ. Spatiotemporal analysis exploring the effect of law enforcement drug market disruptions on overdose, Indianapolis, Indiana, 2020–2021. Am J Public Health. 2023;113:750–758. doi: 10.2105/AJPH.2023.307291.
   PubMed Web of Science ®Google Scholar
• Frohlich KL, Potvin L. The inequality paradox: the population approach and vulnerable populations. Am J Public Health. 2008;98:216–221. doi: 10.2105/AJPH.2007.114777.
   PubMed Web of Science ®Google Scholar
• Opioid-Related Overdose Deaths. All intents, ma residents – demographic data highlights. Massachusetts Department of Health; 2023 Dec [accessed 2024 Apr 15]. https://www.mass.gov/doc/opioid-related-overdose-deaths-demographics-december-2023/download.
   Google Scholar